A

Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ

Research site
(Unclaimed)
Location
4550 East Bell Road Suite 170, Phoenix, Arizona, United States of America
Site insights

Top conditions

Crohn Disease (6 trials)

Rheumatoid Arthritis (5 trials)

Arthritis (5 trials)

Systemic Lupus Erythematosus (3 trials)

Raynaud Disease (2 trials)

Top treatments

Vedolizumab
Mirikizumab
Upadacitinib
Iloprost
Ixekizumab
Secukinumab
RO7123520
Evobrutinib
Tofacitinib
Baricitinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 17
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Locations recently updated
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. Th...

Active, not recruiting
Crohn's Disease
Other: Blood Draw
Other: CDPATH™

The main aim of the study is to check for long-term side effects of Vedolizumab Subcutaneous (also known as Vedolizumab SC) in people with ulcerative...

Active, not recruiting
Colitis, Ulcerative
Crohn's Disease
Drug: Vedolizumab SC

The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoi...

Active, not recruiting
Joint Diseases
Arthritis
Drug: Peresolimab
Drug: Placebo

The primary objectives of the study are to evaluate the efficacy of BIIB059 (litifilimab) compared with placebo in reducing skin disease activity mea...

Enrolling
Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Drug: BIIB059 (litifilimab)
Drug: Placebo

The COVID-19 VaccinE Response in Rheumatology patients (COVER) study is a multicenter randomized controlled trial designed to evaluate the efficacy a...

Enrolling
Psoriatic Arthritis
Spondylarthritis
Drug: Abatacept
Drug: Baricitinib

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling
Systemic Lupus Erythematosus
Drug: Upadacitinib
Drug: Placebo

Trial sponsors

Takeda logo

Takeda (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems